STUDY ON SOME PARAMETERS OF SOMATOSENSORY EVOKED POTENTIAL IN PATIENTS WITH MULTIPLE SCLEROSIS

Nguyễn Thị Vân1, Nguyễn Văn Tuấn1,
1 Vinh Medical University

Main Article Content

Abstract

Objectives: Multiple sclerosis (MS), is an inflammatory disease of the central nervous system in which the formation is very characteristic of demyelinated lesions in the brain and spinal cord. Conducting a diagnosis of Multiple Sclerosis supported by Somatosensory evoked potential (SSEP) is essential, not only for diagnosis, but also for the pathophysiological treatment. Methods: Crosssectional descriptive study of 30 patients at the neurological department of Nghe An hospital from January 2021 to Octorber 2021. Results: the average age of patients with Multiple Sclerosis was 32,73 ± 2,27, commonly from 20 to 50years old. There were 7 males (23.3%) and 23 females (76.7%) enrolled in this study. The incidence of the disease is higher in women than in men, female/male ratio is 3.3:1. The patients with normal N9 waves were common (93.33%), while abnormal N13 waves accounted for 80% and abnormal N20 accounted for 86.7%. Among patients with abnormal N13 waves, the number of patients with increased latent time was 37.5%, or the patients without N13 waves was commonly 62.5%. With N20 waves, 8 patients had increased latent time, 18 patients lost N20 waves (69.2%). The patients with symptoms such as limb numbness and disorder of anal sphincter had abnormal N13 and N20 waves accounting for high percentages (73.3 – 85.7%), while normal N9 waves accounted for the majority. Conclusion: The patients with symptoms such as limb numbness and disorder of anal sphincter had abnormal waves higher than normal waves.

Article Details

References

1. Nguyễn Văn Chương (2018), Xơ não tủy rải rác, Bệnh học thần kinh . Nhà xuất bản Quân đội nhân dân, Hà Nội; 346-351.
2. Nguyễn Hữu Công (2019), Điện thế gợi cảm giác thân thể. Chẩn đoán điện và bệnh lý thần kinh cơ, NXB Y học; 84-95.
3. Compston A. (2019), Distribution of multiple sclerosis. In: Alastair Compston et al eds McAlpine’s Multiple Sclerosis, 3rd edition, Churchill Livingstone, London; 63 – 100.
4. Compston A. (2020), Treatment and management of multiple sclerosis. In: Alastair Compston et al eds McAlpine’s Multiple Sclerosis, 3rd edition, Churchill Livingstone, London; 437 – 498.
5. Kira J. Ishizu T., Osoegawa M. and The Reseach Committee of neuroimmnological diseases (2020), Multiple slerosis in Japan: Nationwide surveys over 30 years, Neurology Asia; 13: 131 – 143.
6. Mc Donald W. I., Compston A., Edan G., Goodkin D., Hartung H. P., Lublin F. D., et al. (2016), “Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis”, Ann Neurol; 50: 121-127.
7. Michael J. Aminnoff & Andrew Eisen (2020), Somatosensory Evoked Potentials (SSEP). In: Electrodignosis in Clinical Neurology, 3th Edition. Churchill Livingstone; 571 – 603.
8. Oger J. (2019), “World Federation of Neurology. Seminars in clinical neurology. Multiple sclerosis for the practicing neurologist”, Demos medical publishing, New York; 112.